CLINICAL_TRIALS
trial_result
· 2021-01-11
Clinical Trial Update: Maximizing Outcome of Multiple Sclerosis Transplantation [Phase 3]
Summary
Phase 3 trial update for a transplantation strategy in relapsing-remitting multiple sclerosis; trial terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Northwestern University | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 3 | Status: TERMINATED | Results posted: 2021-01-11